验证数据展示
经过测试的应用
Positive WB detected in | A549 cells, A431 cells, HeLa cells |
Positive IP detected in | A549 cells |
Positive IHC detected in | human breast cancer tissue, human prostate cancer tissue, human lung cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF/ICC detected in | A549 cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:3000 |
Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
22709-1-AP targets EML4 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human samples.
经测试应用 | WB, IHC, IF/ICC, IP, ELISA Application Description |
经测试反应性 | human |
免疫原 | EML4 fusion protein Ag18463 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | echinoderm microtubule associated protein like 4 |
别名 | Restrictedly overexpressed proliferation-associated protein, EMAPL4, Echinoderm microtubule-associated protein-like 4, C2orf2 |
计算分子量 | 981 aa, 109 kDa |
观测分子量 | 120 kDa |
GenBank蛋白编号 | BC140845 |
基因名称 | EML4 |
Gene ID (NCBI) | 27436 |
RRID | AB_2879153 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen Affinity purified |
UNIPROT ID | Q9HC35 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
实验方案
Product Specific Protocols | |
---|---|
WB protocol for EML4 antibody 22709-1-AP | Download protocol |
IHC protocol for EML4 antibody 22709-1-AP | Download protocol |
IF protocol for EML4 antibody 22709-1-AP | Download protocol |
IP protocol for EML4 antibody 22709-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |